Pfizer Inc. (NYSE:PFE) Receives Average Recommendation of “Moderate Buy” from Analysts
Pfizer Inc. (NYSE:PFE – Get Free Report) has earned an average rating of “Moderate Buy” from the sixteen research firms that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation, five have issued a buy recommendation and two have assigned […]
Pfizer Inc. (NYSE:PFE – Get Free Report) has earned an average rating of “Moderate Buy” from the sixteen research firms that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation, five have issued a buy recommendation and two have assigned […]
